Revvity RVTY Diagnostics — Segment Cost of Revenue

Similar metrics at other companies

GHReportable Segment — Cost of revenue

$101.56M+40.7%

LHDiagnostics — Other Cost and Expense, Operating

$438M+1.8%

LHDiagnostics — Revenue

$2.76B+5.0%

LHDiagnostics — Supplies Expense

$613.5M+4.6%

SPXCDetection and Measurement reportable segment — Cost of products sold

$88.2M+1.6%

LHDiagnostics — Labor and Related Expense

$1.19B+5.7%

Questions, answered.

What is Revvity's diagnostics — segment cost of revenue?

Revvity (RVTY) reported diagnostics — segment cost of revenue of $156.75M in Q1 2026.

How has Revvity's diagnostics — segment cost of revenue changed year-over-year?

Revvity's diagnostics — segment cost of revenue increased by 16.0% year-over-year, from $135.19M to $156.75M.

What is the long-term trend for Revvity's diagnostics — segment cost of revenue?

Over 3 years (2022 to 2025), Revvity's diagnostics — segment cost of revenue has grown at a -3.7% compound annual growth rate (CAGR), from $710.04M to $633.77M.

What does diagnostics — segment cost of revenue mean?

The direct costs required to manufacture and deliver the products sold by the diagnostics segment.

How do you interpret diagnostics — segment cost of revenue?

Rising costs relative to revenue indicate margin compression, while declining costs suggest improved manufacturing efficiency or economies of scale.

How does diagnostics — segment cost of revenue compare across companies?

Standard metric for all manufacturing and product-based companies to assess gross margin health.